Active
Overview
- Legal name
- AMGEN USA INC
- Registered location
- NEWBURY PARK, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Aug 19, 2026
Read company summary
AMGEN USA INC is associated with UEI XPGNQMXHP493 and CAGE 5YNZ4 in public federal records. AcornBids currently links 7 prime awards totaling $840.8M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists NEWBURY PARK, CA, USA.
At a glance
Lifetime prime obligations$840.8M
Prime awards7
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 3, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- AMGEN USA INC
- UEI
- XPGNQMXHP493
- CAGE
- 5YNZ4
- Registered address
- 1 AMGEN CENTER DR, NEWBURY PARK, CA, 91320, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Mar 19, 2026
- Initial registration
- Apr 2, 2010
- Entity start
- Apr 8, 1980
- SAM updated
- Mar 19, 2026
- Registration expires
- Mar 19, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36F79721D008665 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | $3.4B | Feb 1, 2021 | Not available |
| 75A50122C00065TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | Department of Health and Human Services | $839.9M | Sep 30, 2022 | Sep 29, 2032 |
| 36E79725D0053NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | $15.4M | Nov 15, 2025 | Not available |
| 36E79725D00092 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | $100.5M | Feb 26, 2025 | Not available |
| 75A50124C00011VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS… | Department of Health and Human Services | $811.9K | Mar 12, 2024 | Dec 16, 2024 |
| 36E79720D0006ERENUMAB-AOOE 70MG/ML AUTOINJECTOR 1ML ERENUMAB-AOOE 140MG/ML AUTOINJECTOR 1ML | Department of Veterans Affairs | $59.0M | Feb 26, 2020 | Not available |
| 36C26024F0036TAVNEOS (AVACOPAN) | Department of Veterans Affairs | $65.5K | Oct 1, 2023 | Sep 30, 2024 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Mar 19, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Apr 2, 2010 |
| Entity start | Apr 8, 1980 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| JILL FARKAS | Government business | Contact method not published | SAM registration | Not available |
| BARBARA HARD | Alternate government business | Contact method not published | SAM registration | Not available |
| JILL FARKAS | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
About AMGEN USA INC
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 325412 — Pharmaceutical Preparation Manufacturing.
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT; 6505 — Drugs and Biologicals.
Examples from recent award records:
- 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
1 AMGEN CENTER DR, NEWBURY PARK, California 91320, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Veterans Affairs.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit